EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Retrospective Observational Study of Treatment Patterns and Efficacy of onabotulinumtoxinA Therapy in Patients with Refractory Overactive Bladder in Clinical Practice

Kwang Jin Ko iD, Kyu-Sung Lee iD

Toxins · 15.05.2023 · 15 (5) · 338

DOI: 10.3390/toxins15050338 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Toxins, online erschienen am 15.05.2023. Verfasst von Kwang Jin Ko und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06351, Republic of Korea. Hauptthemen laut MEDLINE: Urinary Bladder, Overactive, Botulinum Toxins, Type A. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aimed to evaluate the treatment patterns and long-term efficacy of onabotulinumtoxinA injections in a clinical setting. This single-center retrospective study was conducted on patients with refractory overactive bladder (OAB) aged 18 years or older who received onabotulinumtoxinA 100 IU administered between April 2012 and May 2022. The primary endpoint was the treatment pattern, including the retreatment rate and OAB medication prescription pattern. The duration and effectiveness of onabotulinumtoxinA treatment were analyzed using the overactive bladder symptom score and voiding diaries. A total of 216 patients were enrolled in this study, and the overall patient satisfaction rate was 55.1%. After the first injection, 19.9% received a second treatment, and 6.1% received three or more injections. The median duration until the second injection was 10.7 months. Among the patients, 51.4% resumed OAB medications after 2.96 months. The presence of urodynamic detrusor overactivity was observed only in female patients (odds ratio, 23.65; 95% CI, 1.84 to 304.40), which was associated with a good response. In contrast to clinical trials, the degree of improvement and retreatment rate did not meet expectations. Our findings provide valuable insights into the effectiveness of onabotulinumtoxinA injections in patients with refractory OAB symptoms in real-world practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder, OveractiveBotulinum Toxins, Type AHumansFemaleRetrospective StudiesTreatment OutcomeUrination

Stichwörter der Autor:innen

onabotulinumtoxinAoveractive bladderurinary incontinence

Substanzen

Botulinum Toxins, Type A

Autor:innen und Institutionen

  • Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06351, Republic of Korea.
  • Research Institute for Future Medicine Samsung Medical Center, Seoul 06351, Republic of Korea.

ORCID-Profile: Kwang Jin Ko, Kyu-Sung Lee

Zitieren

APA

Ko, K. J., & Lee, K. S. (2023). Retrospective Observational Study of Treatment Patterns and Efficacy of onabotulinumtoxinA Therapy in Patients with Refractory Overactive Bladder in Clinical Practice. Toxins, 15(5), 338. https://doi.org/10.3390/toxins15050338

Vancouver

Ko KJ, Lee KS. Retrospective Observational Study of Treatment Patterns and Efficacy of onabotulinumtoxinA Therapy in Patients with Refractory Overactive Bladder in Clinical Practice. Toxins. 2023;15(5):338. doi:10.3390/toxins15050338

BibTeX
@article{Ko2023,
  author = {Ko, Kwang Jin and Lee, Kyu-Sung},
  title = {Retrospective Observational Study of Treatment Patterns and Efficacy of onabotulinumtoxinA Therapy in Patients with Refractory Overactive Bladder in Clinical Practice},
  journal = {Toxins},
  year = {2023},
  volume = {15},
  number = {5},
  pages = {338},
  doi = {10.3390/toxins15050338}
}
Kostenlos starten →